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ABSTRACT 
The effects of age on muscle loss and tissue-specific 
levels of NF-ĸB and SIRT6 proteins in rats 
Tiev C. LaGuire 
 
The objective of this study was to examine the influence of age on food intake, tissue and 
organ mass and NF-ĸB and SIRT6 levels in various tissues. The transcription factor, 
Nuclear Factor Kappa-B (NF-ĸB), is associated with both catabolic and anabolic 
pathways of muscle metabolism and may be involved in age-related muscle loss. SIRT6 
is a member of the sirtuin family of proteins that function as protein lysine deacetylases 
and are associated with longevity in a number of organisms. Male Sprague-Dawley rats, 
aged 6 months (Adult) and 21 months (Old) were fed a commercially available diet for 
10-17 days. Old rats consumed less food per body weight (BW) each day than Adult rats 
(1.45% g diet/g BW vs. 2.4% g diet/g BW). However, when intake data were expressed 
as g/diet per day there was no significant difference between groups. For skeletal muscle 
tissue, the average mass of gastrocnemius and soleus (g muscle/g BW) was significantly 
lower in Old rats. Levels of NF-ĸB (p65/RelA) and SIRT6 were measured by Western 
blot analysis in gastrocnemius, tibialis anterior, quadriceps, soleus, lung, heart, kidney 
and liver. NF-ĸB levels were higher in gastrocnemius of Old rats compared to Adult rats. 
No significant age-specific differences in SIRT6 protein levels were noted in the tissues 
examined. Interestingly, when examined independent of age, levels of SIRT6 were 
significantly different between certain tissues. Data from this study suggest that age 
affects muscle loss and NF-ĸB in a tissue-specific manner. Furthermore, these findings 
indicate tissue-specific but not age-specific differences in SIRT6 protein levels. 
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LITERATURE REVIEW 
 
Statistics related to the older population in the U.S. 
 
 The proportion of the U.S. population that is considered to be elderly is increasing 
at a disproportionate rate relative to other age groups.  One of the main reasons this is 
occurring is because of the “Baby Boomers” reaching this age group.  Baby Boomers are 
defined as the population of Americans that were born between 1946 and 1964 
(Administration on Aging, 2012).  In 2011, the oldest members of this cohort turned 65 
years of age and so the first part of an 18-year wave is reaching 65 years of age.  Major 
advances in science and medicine have consistently extended the life span of Americans, 
and thus the combination of factors has led to a large percentage increase in older 
Americans relative to other age groups (Administration on Aging, 2012).    
Since 1900, the percentage of Americans 65+ has more than tripled (from 4.1% in 
1900 to 13.1% in 2010), and the number of persons in this age group has increased 
almost thirteen times (from 3.1 million to 40.4 million).  This trend has continued in more 
recent years.  In the year 2010, approximately 40 million Americans (13% of the 
population) were 65 years of age or older (Administration on Aging, 2012).  This is 
expected to be 20% by the year 2030, or approximately 72.1 million persons.  The older 
population itself is increasingly older and this is adding to the numbers in this group. For 
example, in 2010, the 65-74 age group was 10 times larger than in 1900.  Numbers of 
individuals older than 74 years of age have also increased dramatically (Administration 
on Aging, 2012).  In 2009, persons reaching age 65 had an average life expectancy of an 
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additional 18.8 years (20.0 years for females and 17.3 years for males).  A child born in 
2009 is expected to live 78.2 years.  This is approximately 30 years longer than a child 
born in 1900. Much of this increase occurred because of reduced death rates for children 
and young adults. However, the period of 1990-2007 also has seen reduced death rates 
for the population aged 65-84, especially for men.  Death rates decreased by 41.6% for 
men aged 65-74 and by 29.5% for men aged 75-84 during 1990-2007 (Administration on 
Aging, 2012).   
Having 1 in 5 Americans in the age group of 65 years and older could present a 
multitude of challenges, especially if these individuals are suffering with disabilities or 
poor health.  This high number of individuals reaching 65 years of age will put a strain on 
support systems like this country has never seen before.  There are a number of 
government agencies that focus on the health and well-being of older Americans.  One of 
these agencies is known as the Administration on Aging (AoA) and one of their 
objectives is to consolidate information from numerous other agencies.  One item on the 
AoA website is a report titled, “Older Americans 2012.”  The report was prepared by the 
Federal Interagency Forum on Aging-Related Statistics to provide a comprehensive 
source of information on key indicators of well-being.  The report includes 37 indicators 
that are grouped into five sections: Population, Economics, Health Status, Health Risks 
and Behaviors, and Health Care.  The section on Health Risks and Behaviors includes 
statistics and information on the indicators vaccinations, mammography, diet quality, 
physical activity, obesity, cigarette smoking, air quality, and use of time.  Although each 
of these indicators could be considered relevant to the well-being of older persons it is 
unfortunate that body composition and lean body mass were not included as indicators 
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because they significantly affect health.  However, there is some very interesting data 
about diet, physical activity, and obesity in the report and the highlights are shown and 
briefly discussed below.  Information on the average diet of those 65 years and over is 
shown in Figure 1. Scores are based on The Healthy Eating Index-2005. The index has 12 
components, and a higher score indicates a higher quality diet. Intakes equal to or better 
than the standards set for each component are assigned a maximum score of 100 percent. 
For the nine adequacy components (e.g., total fruit), no intake gets zero percent, and 
scores increase up to 100 percent as the intakes increase toward the standard. The three 
moderation components (e.g., sodium) are scored in reverse; that is, excessively high 
intakes get zero percent and as intakes decrease toward the standard, scores increase up to 
100 percent. Scores are averages across all American adults based on usual dietary 
intake. 
As shown in Figure 1, in 2007-2008 the average dietary intake of older persons 
met the standard (shown as 100%) in only three of the dietary component categories.  
These were the categories of whole fruits, total grains, and meats/beans.  Intakes for the 
other nine categories were below recommendations.  These data suggest that significant 
improvements in nutrient intake for older Americans could be accomplished by 
increasing their intake of whole grains, dark green and orange vegetables and legumes, 
and fat-free or low-fat milk products.  In addition, the intake of foods and beverages with 
sodium, solid fats, alcohol, and added sugars should be reduced.  It stands to reason that 
improving the dietary intake of older Americans could be an effective method to improve 
their health. 
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Figure 1:  Average diet scores for the population 65 and older, by age group, for 
years 2007-2008.  Scores, reported as percentages in this chart, are average Healthy 
Eating Index-2005 scores and not the percentages of individuals who meet the diet 
quality standards. 
b
 Dark green and orange vegetables and legumes. 
c
 Solid fats, alcoholic 
beverages, and added sugars. Reference population: These data refer to the resident non-
institutionalized population. SOURCE: Centers for Disease Control and Prevention, 
National Center for Health Statistics, National Health and Nutrition Examination Survey, 
2007-2008 and U.S. Department of Agriculture, Center for Nutrition Policy and 
Promotion, MyPyramid Equivalents Database 2007-2008 (preliminary), Healthy Eating 
Index-2005.  Figure from:  Administration on Aging, “Older Americans 2012.” 
 
 
 Another way to improve the health of older Americans would be to increase their 
physical activity because many do not engage in regular physical activity.  In an effort to 
promote physical activity, the Office of Disease Prevention and Health Promotion and the 
President’s Council on Fitness, Sports and Nutrition released the 2008 Physical Activity 
Guidelines (health.gov/paguidelines/guidelines/).  The guidelines include a chapter for 
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Active Older Adults for those aged 65 years and older.  The guidelines acknowledge that 
fitness levels vary widely in this age group and state “the chapter focuses on physical 
activity beyond baseline activity” and it is evident that the guidelines represent a rigorous 
expectation. 
The basic guidelines for substantial health benefits are that adults perform at least 
150 minutes (2 hours and 30 minutes) a week of moderate-intensity, or 75 minutes (1 
hour and 15 minutes) a week of vigorous-intensity aerobic physical activity, or an 
equivalent combination of moderate- and vigorous-intensity aerobic activity. Aerobic 
activity should be performed in episodes of at least 10 minutes, and preferably, it should 
be spread throughout the week. The 2008 guidelines also recommend that adults perform 
muscle-strengthening activities that are moderate or high intensity and involve all major 
muscle groups on two or more days a week, because these activities provide additional 
health benefits (U.S. Department of Health and Human Services, 2008).  
As mentioned above, these would appear to be quite rigorous for adults 65 years o 
age and older.  However, it does state that for “adults aged 65 and older who are fit and 
have no limiting chronic conditions, the guidance in this chapter is essentially the same as 
that provided in Chapter 4 – Active Adults.”  Chapter 4 provides guidance for most men 
and women aged 18 to 64 years of age.  So, essentially many of the HHS physical 
activity guidelines for a person older than 65 without limiting chronic conditions are the 
same as an 18 year old.  This seems to be an unrealistic expectation for older adults and 
sheds light on why such a large percentage of adults 65 years and older do not meet these 
physical activity guidelines (Figure 2).  However, it also seems likely that not enough 
adults in this age category are exercising at optimal levels. 
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As Figure 2 indicates, most older Americans do not perform adequate amounts of 
physical activity.  In 2010 only about 11 percent of people age 65 and over reported 
participating in leisure-time aerobic and muscle-strengthening activities that met the 2008 
Federal physical activity guidelines.  Unfortunately, the percentage of older people 
meeting the physical activity guidelines decreased with age, ranging from 14 percent 
among people age 65–74 to 4 percent among people age 85 and over.  There were also 
gender and ethnicity specific differences as men age 65 and over were more likely than 
women in the same age group to meet the physical activity guidelines (14 percent and 8 
percent, respectively, in 2010).  Older non-Hispanic Whites reported higher levels of 
physical activity than non-Hispanic Blacks (12 percent compared with 5 percent).  
Fortunately, the trend seems to be improving because the percentage of older people 
meeting the Federal physical activity guidelines increased over time. In 1998, about 6 
percent of people age 65 and over met the guidelines, compared with 11 percent in 2010.  
However, significant progress needs to be made if the health and well-being of seniors is 
to be improved by physical activity. 
Obesity is another key indicator of health that was included in the Older 
Americans 2012 report.  Obesity is associated with premature death and a number of 
chronic diseases.  Data from the report are shown below in Figure 3.  As with other age 
groups, the percentage of obese persons in the over 65 group has increased in recent 
years.  Between 1988-1994 approximately 22% of persons over 65 were obese but that 
increased to 38% of in 2009-2010.  This represented increases in both genders. 
 In summary, there has been a significant increase in the segment of our population 
that is 65 years of age and older in the U.S. in recent years and it will likely continue to 
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increase for years.  This will pose a tremendous burden on the support systems specific to 
the elderly.  Data related to the health of this population is extremely important if we are 
going to optimize our ability to support their well-being and help them to live quality 
lives in their older years.  Some data already indicates there are areas that appear to be 
logical targets for improvement.  For example, it appears that programs should focus on 
improving the diet, increasing physical activity level, and reducing the prevalence of 
obesity would help seniors live longer healthier lives. 
 
 
Figure 2:  Percentage of people 45 and over who reported participating in leisure-
time aerobic and muscle-strengthening activities that meet the 2008 Federal physical 
activity guidelines, by age group, selected years 1998-2010.  NOTE: This measure of 
physical activity differs from previous editions of Older Americans. The measure reflects 
the 2008 Federal physical activity guidelines for Americans (available from: 
http://www.health.gov /PAGuidelines/). The measure shown here presents the percentage 
of people who fully met both the aerobic activity and muscle-strengthening guidelines. 
Reference population: These data refer to the civilian non-institutionalized population. 
SOURCE: Centers for Disease Control and Prevention, National Center for Health 
Statistics, National Health Interview Survey.  Figure from: Administration on Aging, 
Older Americans 2012. 
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Figure 3:  Percentage of population age 65 and over who are obese, by sex and age 
group in the selected years of 1988-2010.  Data are based on measured height and 
weight. Height was measured without shoes. Obese is defined by a BMI of 30 kilograms/ 
meter
2
 or greater. The percentage of people who are obese is a subset of the percentage of 
those who are overweight. See data source for the definition of BMI. Reference 
population: These data refer to the civilian non-institutionalized population.  SOURCE: 
Centers for Disease Control and Prevention, National Center for Health Statistics, 
National Health and Nutrition Examination Survey.  Figure from: Administration on 
Aging, “Older Americans 2012.” 
 
 
 Definition of Aging 
 
 There are numerous ways to define aging.  Aging may be defined as the 
biological impairment of normal function probably as a result of changes made to cells 
and structural components such as bone and muscle.  Aging can also be thought of as the 
accumulation of changes in a person or organism over time and it must be considered that 
changes can be either advantageous or detrimental depending on how early or late it 
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occurs in the lifespan.  For example, during the developmental period many changes from 
age are advantageous and necessary for optimal health and survival.  Biological aging is 
also sometimes referred to as “senescence” and is considered the changes in the biology 
of an organism after it reaches maturity.  In fact, the word senescence is derived from the 
Latin word senescere, which means “to grow old.”  In humans, it is a multidimensional 
process that includes biological, functional, and social change.  There are numerous 
theories as to how and why the changes occur and the study of aging is the focus of much 
research as scientists attempt to determine if there are ways to slow, avoid, or even 
reverse the effects of aging.   
 
Loss of Muscle During Disease and Aging 
 
 In general, the loss of muscle is a common occurrence in aging and many 
diseases.  In some instances muscle loss also occurs because of disease and aging 
simultaneously.  Muscle loss associated with disease is often referred to as cachexia 
while muscle loss as part of aging is often termed sarcopenia.  Prevalence and a brief 
description of cachexia and sarcopenia are in the following sections. 
 
Cachexia 
 
 The term cachexia is derived from Greek terms meaning “bad condition.”  
Cachexia is associated with various disease conditions that include involuntary muscle 
loss.  A further definition of cachexia is a syndrome with numerous causes that leads to 
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loss of body weight, fat and muscle because of increased protein catabolism (Anker and 
Sharma 2002).  Common diseases associated with cachexia include cancer, chronic heart 
failure and chronic obstructive pulmonary disease.  The tissue loss of cachexia 
compromises the quality of life by reducing strength and endurance and it likely increases 
the risk of acquiring other illnesses and diseases.  This results in a very poor prognosis 
for those afflicted with cachexia (Glass and Roubenoff, 2010).  
 Cancer cachexia is present in most types of cancer and can be the factor that 
eventually leads to mortality.  The loss of body mass of cachexia is due to a variety of 
factors including tumor-derived factors, anorexia, endocrine changes and alterations in 
signaling molecules such as the cytokines.  Probably the most well studied cytokine 
related to cachexia is tumor necrosis factor-α (TNF-α).  During its initial characterization, 
this cytokine was found to be the same as a previously discovered protein, called 
cachectin, that was able to induce cachexia.  TNF-α induces a variety of effects including 
induction of skeletal muscle catabolism via the ubiquitin-proteasome system (UPS) 
(Mitch and Price, 2001).  Other cytokines are also involved and the combination of 
cytokine alterations and other factors can result in body mass loss even in the absence of 
anorexia.  Unfortunately, there are no approved agents for the treatment of cancer 
cachexia so this represents a significant void in cancer patient care. 
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Sarcopenia 
 
 The term sarcopenia refers to the loss of muscle mass and function associated 
with aging (Rosenberg, 1997).  Although its etiology is not fully defined there are a 
number of factors that are part of old age and appear to contribute to sarcopenia.  Some of 
the major factors include an increase in inflammatory cytokines (Alemán et al., 2011; 
Visser et al., 2002), decreased physical activity (Klitgaard et al., 1990), bedrest 
(Kortebein et al., 2007), and oxidative stress and hormonal alterations (Kley et al., 2007; 
Malafarina et al., 2012).  In addition to these factors, dietary intake has also been shown 
to play a vital role in sarcopenia.  Studies have shown that inadequate food intake may be 
one of the major causes as inadequate protein intake increases the rate of loss of lean 
body mass as the body responds metabolically to compensate (Andrews et al., 2006).  
Indeed, numerous studies have indicated that the Recommended Dietary Allowance 
(RDA) of 0.8 g/kg/day for protein intake is not adequate for the elderly.  Research 
suggests it should be adjusted to approximately 1.25 – 1.5 g/kg/day to promote better 
overall health and decrease loss of lean mass in older individuals (Wolfe et al., 2008; 
Evans, 1995).  Therefore, protein intake and/or improved dietary protein quality should 
be examined in persons that may suffer from sarcopenia as at least one means to protect 
against the condition. 
 Unlike cachexia, sarcopenia is not considered to be a disease.  Even though a 
widely accepted definition of sarcopenia has not been defined, in general, groups working 
to define it agree that the definition should include criteria specific for both muscle and 
concomitant loss of function.  For example, the Society on Sarcopenia, Cachexia, and 
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Wasting Disorders has defined it based on results from a walking test when a person 
walks <1 m/sec, or less than 400 meters covered in six minutes with a lean body mass 
<7.23 kg/m
2
 in men and <5.67 kg/m
2
 in women as measured by Dual-energy X-ray 
Absorptiometry (DXA) (Muscaratoli et al., 2010).  Other groups have also defined 
sarcopenia but with slightly different criteria and this had led to discrepancies in 
estimations of prevalence and effectiveness of treatments.  However, there is no doubt 
that significant numbers of persons are affected throughout the world.  Melton et al. 
estimated the prevalence to be between 13-24% in adults over 60 years of age and more 
than 50% in those 80 years of age and older (Melton et al., 2000).  A different study 
estimated the prevalence at 5-13% for those 60-70 years of age and 11-50% in those aged 
80 years and above (Von Haehling et al., 2010).  Estimates put the number of sarcopenia-
related disability in the >60-year-old population to be between 5 and 10% and this 
translates to about 7-10 million patients in the U.S. and European Union.  In the U.S., it 
has been estimated that direct healthcare costs attributable to sarcopenia are at $18.5 
billion per year (Janssen et al., 2004).  Obviously, it would be advantageous from both 
the personal and healthcare system perspectives if more effective treatments could be 
developed to decrease the incidence and detrimental effects of sarcopenia. 
 Up to this point exercise, particularly resistance exercise, is the only proven 
treatment for preventing or reducing muscle wasting.  However, there are inherent 
difficulties in prescribing exercise to large populations and especially in the elderly.  
Exercise programs in the elderly requires trained persons to instruct as well as adequate 
and appropriate facilities and equipment to support the regimens.  It also requires that the 
elderly person is motivated not only to start but also to consistently partake in the 
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program.  Unfortunately the persons affected often would not enjoy exercise and that 
might be why they have the condition in the first place.  Moreover, they may be suffering 
from physical pain and ailments that make the exercise regimen difficult to perform.  So, 
when these aspects are considered with exercise regimens it stands to reason that the 
discovery of effective dietary or pharmacological treatments that minimize incidence or 
effects of sarcopenia would be highly advantageous.  Unfortunately, this has also proven 
to be problematic.  Future work must also continue to define and describe intracellular 
molecular factors that regulate processes related to aging.  Elucidating details of 
intracellular events is a crucial part of understanding aging and evaluating effects of 
certain treatment strategies. 
 
Putative Causes and Theories of Aging 
 
 Because senescence affects every human being, there is a tremendous amount of 
research examining the process of aging.  As findings have accumulated, a number of 
models and theories have developed and have been tested in an attempt to explain aging.  
Some of the theories are based on evolutionary events and involve the accumulation of 
changes to an organism’s makeup over time.  Some of the theories of aging involve 
specific physiologic and/or cellular alterations that occur and may explain why an 
organism such as humans age during their lifetime.  A number of the physiologic and 
cellular theories are identified and briefly explained below.  
 The telomere theory of aging hypothesizes that normal somatic cells have a finite 
lifespan that is determined by the length of their telomeric DNA.  Telomeric DNA 
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consists of long repeating sequences that are located at the ends of chromosomal DNA 
and are added and maintained by an enzyme known as telomerase (Artandi, 2006).  Cells 
typically seem to lose telomeric DNA as they divide and when this DNA reaches a 
specific shortened length the cells tend to enter senescence and stop dividing.  Indeed, 
this is an intriguing theory as the promotion of telomerase activity and re-lengthening of 
telomerase activity in human senescent cells allowed the cells to exit senescence and 
replicate (Vaziri and Benchimol, 1998).  Research related to this theory has continued 
and this is still considered to be a relevant theory of aging.   
The autoimmune theory of aging states that the body later in life begins to 
produce autoantibodies against its own tissues and/or there are time-acquired deficits in 
T-cell function (Walford, 1969; Kent, 1977; Pawelec et al., 2004).  These changes make 
the body susceptible to infections, cancer, and other chronic diseases, especially 
autoimmune diseases.  The role of autoimmune aberrations in aging, like many other 
theories, remains to be determined.  However, there is indeed strong evidence that the 
immune system is involved in the aging process and this has led to the term “inflamm-
aging” to describe the process.  In this model, innate immunity seems to be activated and 
this causes systemic inflammation that alters both systems and cellular processes and 
these contribute to the aging phenotype (Salminen et al., 2008).  One of the key 
molecules in this process appears to be the well-known, well-described transcription 
factor complex known as NF-ĸB.  This is one of the most studied theories in aging and 
will be discussed in greater detail in the subsequent section on NF-ĸB.   
Considerable attention has also been placed on epigenetics and aging.  The term 
epigenetics was coined to explain alterations related to genes and their expression but that 
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do not directly alter the nucleotide sequence of the gene.  The alterations include 
structural modifications to chromatin that regulate the transcription of certain genes.  
These modifications include DNA-methylation, histone acetylation, imprinting, RNA-
interference, gene silencing, and paramutations (Allis et al., 2007).  Epigenetics plays a 
role in regulating numerous genes that have been shown to have roles in aging and 
shorten lifespan.  One of the best examples of how epigenetics is related to aging is the 
gene in yeast known as SIR-2.  Genetic studies showed caloric restriction increased 
longevity and that SIR-2 was involved and subsequently it was shown that SIR-2 is a 
member of a family of genes now known as the SIRTs (sirtuins) that are expressed in a 
wide variety of organisms including humans.  Mechanistic studies subsequently showed 
that SIRTs are deacetylases that modify chromatin structure to modulate transcription of 
genes via epigenetics.  The SIRTs and epigenetics are one of the most researched aging 
theories and will be discussed in greater detail in a later section. 
When caloric restriction was first found to increase longevity in rats (McCay et 
al., 1939), researchers began to perform follow up studies designed to determine the 
mechanisms involved.  Eventually a theory developed that suggested that the reason 
caloric restriction promoted longevity was because fewer free radicals (also known as 
reactive oxygen species (ROS)) were formed due to less metabolism of energy producing 
substrates.  This is now known as the free radical theory of aging of Harman and it 
proposes that during aging macromolecules are oxidized and accumulate to compromise 
cellular functions and shorten lifespan (Harman, 1968).  The free radicals damage cellular 
membranes, proteins and DNA, as well as other molecules, and it was hypothesized that 
the damage to mitochondria was especially harmful and was linked to lifespan (Harman, 
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2006). 
However, recent studies have indicated there are shortcomings to the free radical 
theory of aging.  For example, nutritional and genetic strategies that increase anti-
oxidants typically have not resulted in an increased lifespan.  For example, when the 
results of nineteen clinical trials with vitamin E supplementation were compiled there 
appeared to be no reduction in mortality (Miller et al., 2005).  Supplementation with 
vitamin C also appeared to have no significant benefit to lifespan extension (Bjelakovic 
et al., 2007).  Studies using molecular techniques to increase levels of key anti-oxidant 
enzymes had mixed results with some having no effect while others increased lifespan of 
mice (Perez et al., 2009; Mitsui et al., 2002; Schriner et al., 2005).  Another challenge to 
the free radical theory of aging is that of exercise.  In general, exercise increases free 
radical production (Powers and Jackson, 2008) and cellular damage and yet exercise 
generally enhances human aging (Nakamura et al., 1996) and extends lifespan in mice 
(Navarro et al., 2004) and rats (Holloszy et al., 1985).  Overall, there is validity in the 
free radical theory of aging but it does not account for all aspects of the aging process.          
 
Sirtuins and Longevity 
 
 In the late 1980’s, a group of genes was first described in the yeast 
Saccharomyces cerevisiae as having a role in determining yeast mating types.  The genes 
were called the SIR (silent information regulator) genes because they could 
transcriptionally repress the silent mating loci known as HML and HMR (Ivy et al., 1986; 
Rine & Herskowitz, 1987).  Additional roles were also characterized for the SIR genes 
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but in the late 1990’s a breakthrough was made that linked one of the SIR genes to 
increased lifespan (longevity) in yeast and subsequent research into their functions 
increased exponentially.  The breakthrough was in 1999 when Kaeberlein et al. showed 
that the yeast SIR-2 gene decreased lifespan when it was mutated but increased lifespan 
when the wildtype SIR-2 expression was increased (Kaeberlein et al., 1999).  As 
mentioned previously, years ago a study (McCay et al., 1939) showed that caloric 
restriction (CR) in rats extended their lifespan.  Additional studies in several species and 
organisms indicated that CR extends their lifespans as well.  A follow–up study, by the 
same research group that showed SIR-2 increased longevity, provided evidence that 
caloric restriction could not increase longevity in SIR-2 mutant yeast.  This indicated that 
SIR-2 was indeed required for the increased lifespan with caloric restriction (Lin et al., 
2000).  Subsequent analysis indicated SIRT1 is the mammalian homolog of the yeast 
SIR-2.  It has since been determined that mammals express seven homologs of yeast SIR-
2 and they are known as Sirtuins 1-7 (Taylor et al., 2008).  However, it has been shown 
that SIRT1 has the closest structural and sequence similarities to SIR-2, hence it received 
the most attention in the initial phase of research in mammalian sirtuins.    
   There are now a multitude of details known about the Sirtuins.  The Sirtuins are 
NAD-dependent deacetylases that remove acetyl groups from amino acid residues of 
histone proteins.  SIR-2 and SIRT1 were the first in the group to be identified as a 
deacetylase (Imai et al., 2000).  Acetylation of lysine residues is a common post-
translational modification often used in epigenetic regulation (Figure 4).  By 
deacetylating histones the SIRTs alter chromatin structure and modulate expression of 
genes involved in a wide range of activities and different tissues. 
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Recent work has indicated that SIRTs also deacetylate molecules that are not 
histones.  For example, SIRT1 deacetylates cytosolic acetyl-CoA synthetase (Hallows et 
al., 2006), a key enzyme in fatty acid synthesis.  SIRT1 also deacetylates several 
transcription factors including PGC-1α (Rogers et al., 2005).  In this process, fasting 
induces SIRT1 protein in the liver which then interacts with and deacetylates PGC-1α 
which induces gluconeogenic genes and hepatic glucose output.  In addition, the 
deacetylation of PGC-1α by SIRT1 caused repression of hepatic glycolysis in fasting 
(Rodgers et al., 2005) (Figure 5).  These findings implicate SIRT1 as a key regulator of 
energy homeostasis in addition to its originally described roles.  Like SIRT1, AMP-
activated protein kinase (AMPK) responds to nutritional and metabolic cues, mostly by 
sensing AMP levels, and can affect the activity of a variety of processes related to energy 
metabolism (Canto et al., 2009).  Overall, AMPK responds to increases in cellular AMP 
by increasing the activity of pathways / processes that produce ATP production while 
decreasing processes that require ATP (Canto et al., 2009).  A significant number of 
studies have shown that SIRT1 and AMPK often work in a coordinated fashion to 
regulate energy-related pathways (Figure 5) (Canto el al., 2009; Fulco and Sartorelli, 
2008; Price et al., 2012; Choi et al., 2013). 
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Figure 4:  Modification of histones by lysine acetylation.  The modification relaxes the 
chromatin structure and facilitates gene expression.  SIRTs reverse the process through 
deacetylation and repression of gene expression. 
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Figure 5:  SIRT1 activation alters hepatic glucose and fatty acid metabolism by 
deacetylation of PGC-1α. 
 
 
 
 Other studies have shown that SIRT1 deacetylates transcription factors that are 
involved in the mammalian cellular stress response.  Findings reported by Brunet et al., 
(2004), provided evidence that SIRT1 interacted with members of the stress-response 
FOXO transcription factor family known as Forkhead.  Specifically, it was found that 
SIRT1 and the transcription factor FOXO3 formed a complex when cells were exposed to 
oxidative stress.  When this occurred, SIRT1 deacetylated FOXO3 and increased 
FOXO3’s ability to induce cell cycle arrest (Figure 6).  This also inhibited FOXO3’s 
ability to induce cell death.  This implies that “one way in which members of the SIR-2 
family of proteins may increase organismal longevity is by tipping FOXO-dependent 
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responses away from apoptosis and toward stress resistance” (Brunet et al., 2004).  
Another intriguing finding was that SIRT1 physically binds to a component of NF-ĸB 
and inhibits its effects on gene expression (Yeung et al., 2004).  Therefore, perhaps at 
least one member of the Sirtuin family may enhance longevity by decreasing the 
inflamm-aging process via NF-ĸB. These findings suggest that the elevation of SIRT1 
levels associated with caloric restriction may impart some of its increased longevity 
effects by decreasing the effects of NF-ĸB. 
 
 
Figure 6:  SIRT1 binds and deacetylates FOXO3 to affect cell cycle arrest. 
 
 
In addition, recent work has also shown beneficial effects of dietary components 
such as quercetin (a natural polyphenolic flavonoid) and resveratrol (a polyphenol found 
in relatively high amounts in grapes) may be via activation of SIRT1 (Davis et al., 2009; 
Knutson and Leeuwenburgh, 2008).  SIRT1 has also been reported to modulate plasma 
glucose levels and insulin sensitivity of tissues (Metoyer and Pruitt, 2008).  There is now 
a significant number of studies on how dietary components regulate SIRT1 and other 
SIRT family members.  In fact, the number of studies is too significant to report in this 
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review of literature.  In view of the findings related to the multiple roles of SIRT1 in 
regulating so many vital processes including lifespan, it seems likely the investigation of 
ways to manipulate SIRT activity via dietary and lifestyle options will expand 
dramatically in the near future. 
 
Characterization of the Sirtuins 
 
Research is underway to characterize other Sirtuin family members and as a result 
it has been shown that SIRTs 1, 2, 6, and 7 reside mostly in the nucleus but 3, 4, and 5 are 
in the mitochondria most of the time.  SIRT3 is especially intriguing because it has been 
shown to shuttle from the cytosol to the mitochondria during cellular stress (Scher et al., 
2007).  This protein appears to have effects on multiple cellular components including 
genes in the nucleus and the mitochondria although most of its effects appear to be in 
mitochondria.  For example, a recent study by Ahn et al., (2008) indicated SIRT3 
upregulates ATP production by enhancing levels of electron transport chain Complex I 
components.  In addition, it was recently shown that SIRT3 levels significantly decreased 
with age and this was associated with decreased ATP production (Lanza et al., 2008).   
Protein acetylation in the mitochondria is now believed to be a significant part of 
regulation of mitochondrial processes (Zhao et al., 2010).  A recent study reported 
acetylated sites on 195 proteins including a significant number of non-histone proteins.  It 
is of interest that 133 of the proteins were mitochondrial proteins (Kim et al., 2006).  
SIRT3 appears to be the major regulator of mitochondrial acetylation and this is 
supported by experiments that showed no significant differences in mitochondrial 
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acetylation were found in mice lacking SIRT4 and 5 (Lombard et al., 2007) while 
hyperacetylation was observed in SIRT3 null mice.  Low SIRT3 is also implicated as 
having a role in the hyperacetylation of mitochondrial protein that occurs in mice with a 
fatty liver due to a chronic high fat diet (Kendrick et al., 2011).  In the livers of mice fed 
a high-fat diet there was a decrease in SIRT3 activity, a 3-fold decrease in NAD+ levels 
and increased oxidation of mitochondrial proteins.  This was associated with reduced 
activity of electron transport chain Complexes III and IV and this could increase the risk 
of hepatic lipotoxicity (Kendrick et al., 2011) (Figure 7).  Therefore it appears that SIRT3 
is a key regulator of mitochondrial metabolism and is sensitive to dietary effectors such 
as a high fat diet. 
 
 
 
Figure 7:  Effects of a high fat diet on SIRT3 and associated factors in mice. 
 
 
Although the mechanisms remain largely unexplained, evidence suggests that 
some of the beneficial effects of CR on longevity involve alterations in mitochondrial 
functions (Anderson et al., 2008).  Studies have shown that CR tends to increase 
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mitochondrial biogenesis and decrease reactive oxygen species (ROS) in mammals and 
these responses tend to decrease oxidative damage to macromolecules and cellular 
damage, two items that are associated with reduced longevity (Figure 8).  Because of the 
vital role acetylation plays in mitochondrial function it stands to reason that acetylation is 
involved in CR and that SIRT3 must play a role.  Indeed, it has been shown that SIRT3 
increases mitochondrial biogenesis via activation of the transcription factor known as 
PGC-1α (Palacios et al., 2009; Pillai et al., 2010; Shi et al., 2005).  The reciprocal is also 
true as PGC-1α stimulates SIRT3 expression by binding to the SIRT3 promoter (Kong et 
al., 2010) (Figure 8).  PGC-1α is a co-activator protein that is responsible for affecting 
the expression of a large number of genes, in fact so many that it is referred to as a master 
regulator of gene expression and metabolism.  Given the apparent connection between 
SIRT3 and PGC-1α there seems no doubt that SIRT3 has the ability to regulate a high 
number of cellular processes to affect the status and longevity of organisms. 
Less is known about the roles of SIRTs 4 and 5 as compared to SIRTs 1 and 3.  
SIRT4 is present in the mitochondrial matrix and is highly expressed in kidney, heart, 
brain, liver, and pancreatic beta-cells (Ahuja et al., 2007; Haigis et al., 2006).  During CR 
SIRT4 expression declines in the liver but its levels increase in genetic models used to 
mimic diabetes (Haigis et al., 2006; Nasrin et al., 2010).  Interestingly, to this point no 
deacetylase activity has been found for SIRT4 (Aluja et al., 2007; Haigis et al., 2006).  
However, it has been shown in mice that SIRT4 uses ADP to ribosylate glutamate 
dehydrogenase (GDH) resulting in inactivation of the enzyme (Haigis et al., 2006).  GDH 
converts glutamate to α-ketoglutarate and repression of GDH by SIRT4 decreases the  
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Figure 8:  The effects of caloric restriction on SIRT3 activity, mitochondrial 
biogenesis, and longevity. 
 
 
amino acid stimulation of insulin secretion from pancreatic beta-cells (Haigis et al., 2006) 
(Figure 9).  Therefore, reduced SIRT4 activity allows higher GDH activity and amino 
acid-stimulated insulin secretion during CR when amino acids are being used as an 
energy source at a higher level.  Another recent study has also shown that SIRT4 
knockdown in tissue culture and mouse liver cells caused increased expression of fatty 
acid metabolism enzymes (Nasrin et al., 2010).  Whether or not SIRT4 will be found to 
have deacetylase activity remains to be determined.  However, it is already apparent that 
SIRT4 plays a role in regulating energy pathways. 
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Figure 9:  SIRT4 inactivates glutamate dehydrogenase (GDH) by ribosylation.  The 
result tends to be decreased insulin stimulation. 
 
 
SIRT5 appears to differ from SIRTs 3 and 4 in that its liver levels do not seem to 
change in response to CR (Nakagawa et al., 2009; Schwer et al., 2009).  SIRT5 null mice 
do not show any major phenotype and there is not a difference in mitochondrial 
acetylation of proteins (Lombard et al., 2007) indicating a distinction from SIRT3 null 
mice.  SIRT5 does not appear to have robust deacetylase activity with respect to histone 
proteins (Black et al., 2008; Schlicker et al., 2008).  However, it has been shown that 
SIRT5 interacts with and deacetylates carbamoyl phosphate synthetase 1 (CPS1) and this 
activates the enzyme (Nakagawa et al., 2009) (Figure 10).  CPS1 combines ammonia 
with carbon dioxide in the first, rate-limiting step of the urea cycle in the mitochondria of 
liver cells.  The study by Nakagawa et al., (2009) showed that SIRT5-deficient mice had 
elevated levels of ammonia during a prolonged fast due to insufficient up-regulation of 
CPS1 activity.  Therefore, SIRT5 appears to play a key role in the regulation of the urea 
cycle and ammonia disposal.  To date, this is the only known role for SIRT5 but it seems 
likely that additional functions will be uncovered. 
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Figure 10:  SIRT5 activates carbamoyl phosphate synthetase 1 (CPS1) by 
deacetylation. 
 
 
Defining a Role for SIRT6  
 
 SIRT6 is one of the well-characterized members of the SIRTs family and it has 
been described as having a role in numerous functions.  A few years ago, Michishita et 
al., (2008) provided evidence that SIRT6 binds to telomere chromatin and can modify its 
structure by functioning as a NAD-dependent deacetylase.  Their work indicated SIRT6 
could remove an acetyl group from histone H3 lysine 9 (H3K9) and that this can modify 
the structure of the telomeric chromatin.  Telomeres are long repeating sequences of 
DNA that exist on the ends of each of the chromosomes (McClintock, 1941; Artandi, 
2006).  Maintenance of telomere structure has been shown to be vital in protecting 
against genomic instability and that telomere dysfunction can lead to tumor formation 
(Gisselsson et al., 2001; Meeker et al., 2004).  Michishita et al., (2008) utilized 
knockdown experiments and provided evidence that loss of SIRT6 function results in 
complications similar to Werner Syndrome (Multani et al., 2007).   Additional work by 
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this research group showed that SIRT6 is also involved in H3K56 deacetylation and that 
this is important for the regulation of cell cycle arrest (Michishita et al., 2009). Therefore, 
the last few years have suggested that SIRT6 has an important role in protecting cellular 
telomere structure thereby maintaining proper regulation of the cell cycle and potentially 
protecting against cancer.  Consequently SIRT6 may be important for protection against 
cancer since dysfunction of telomere structure and cell cycle regulation may lead to 
cancer. 
 Another theory related to tumorigenesis is that cells must accumulate several 
DNA mutations as they change from normal cells to cancer cells.  Because cells have 
several DNA repair mechanisms/pathways there is typically an inherent ability to repair 
DNA before mutations cause cellular transformation to cancerous cells.  One of the first 
studies to link SIRT6 to the DNA repair systems was one using SIRT6 deficient mouse 
embryonic fibroblasts (MEFs) and stem cells (Mostoslavsky et al., 2006).  It was reported 
that SIRT6 deficient cells were more sensitive to DNA damaging agents and they divided 
more slowly than wildtype cells.  The data also indicated that SIRT6 was involved in 
regulating base excision repair (BER), one of the DNA repair pathways (Mostoslavsky et 
al., 2006).  However, at this point the precise role of SIRT6 in BER is yet to be defined. 
 Another DNA maintenance mechanism is the repair of double-strand breaks 
(DSB) in the DNA structure.  When DNA contains a mutation that is more significant 
than a single nucleotide mismatch then a DSB is a typical result.  The DSB can then lead 
to chromosomal end fusion and genomic instability.  In 2009, McCord et al. showed that 
SIRT6 participates in DSB DNA repair by forming a macromolecular complex with the 
DNA DSB repair protein DNA-dependent protein kinase.  The interaction with SIRT6 
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stabilizes the kinase attachment to chromatin and facilitates DSB repair (McCord et al., 
2009).  In 2011 it was reported that oxidative stress leading to DSB causes SIRT6 to 
translocate to the site of the DNA DSB (Mao et al., 2011).  These studies suggest an 
important role for SIRT6 in genomic stability because SIRT6 appears to support DSB 
repair.  SIRT6 was found to associate with Poly-ADP-ribose Polymerase 1 (PARP1) 
during the conditions of oxidative stress.  PARP1 is an enzyme that modifies nuclear 
proteins by ADP-ribosylation and is involved in a number of processes including DNA 
repair.  The result of SIRT6-PARP1 association was ribosylation of lysine residue 521 of 
PARP1 and its activation which enhanced DSB repair during the oxidative stress 
conditions (Mao et al., 2011).  In summary, it appears SIRT6 is important for DNA repair 
by both the BER and DSB pathways. 
 
SIRT6-Deficient Phenotype 
 
SIRT6 deficiency appears to have more detrimental effects as compared to 
deficiencies of the other SIRT family members.  Work by Mostoslavsky et al., (2006) 
described the phenotype of SIRT6 knockout mice as one that leads to numerous 
abnormalities early in the life cycle.  The mice are born with an apparently normal 
phenotype but it digresses rapidly and at about three weeks of age they develop severe 
conditions that lead to death at about four weeks of age.  Metabolic defects are significant 
and include low levels of serum IGF-1 and acute onset of hypoglycemia.  The SIRT6-
deficient mice also exhibit total loss of subcutaneous fat, osteopenia and lymphopenia 
among documented conditions (Mostoslavsky et al., 2006).  Based on the phenotype of 
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SIRT6 knockout mice it is obvious that SIRT6 plays a crucial role in vital processes 
although the precise relationship between SIRT6 function and each of the observed 
complications is not known. 
 Recent work using the SIRT6 knockout model has provided important 
information in defining the role of SIRT6 in glucose homeostasis and how it may relate 
to lifespan (Zhong et al., 2010).  SIRT6 deficiency results in lethal hypoglycemia at 
approximately four weeks of age.  The hypoglycemia occurs in the context of increased 
glucose uptake into brown adipose tissue and muscle tissue.  Blood insulin levels were 
low and hepatic gluconeogenesis was elevated suggesting that the pancreas and liver 
were responding to low blood glucose rather than causing it (Zhong et al., 2010).  
Additional experiments showed that SIRT6 deficiency caused elevated mRNA and 
protein levels of the membrane glucose transporter GLUT1.  Moreover, the expression 
levels of five key glycolytic genes were increased (Zhong et al., 2010).  Chromatin 
immunoprecipitation (ChIP) assays indicated that SIRT6 bound to the promoter regions 
of the five glycolytic genes and that SIRT6 deficiency increased histone H3K9 
acetylation of the promoters of these genes (Zhong et al., 2010).  Because the hypoxia-
inducible transcription factor Hif1α is an important regulator of enhanced glucose 
utilization under certain conditions (Lum et al., 2007; Seagroves et al., 2001), 
investigators have focused on it to determine if there was an interaction between Hif1α 
and SIRT6.  Co-immunoprecipitation assays provided evidence that there was an 
interaction between the two proteins and that SIRT6 normally represses the activity of 
Hif1α (Zhong et al., 2010).  Further experimentation revealed that SIRT6 relies upon its 
interaction with Hif1α in an important regulatory mechanism to control glucose 
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metabolism (Zhong et al., 2010).  These findings indicate that SIRT6 functions as a 
H3K9 deacetylase to decrease glucose metabolism. 
 
SIRT6 Over-expression and Effects on Metabolism and Lifespan 
 
Researchers recently found that male transgenic mice overexpressing SIRT6 had a 
significantly longer lifespan than wild-type (WT) mice (Kanfi et al., 2012).  Interestingly, 
there was not enhanced lifespan in the female transgenic mice of the same study.  
Researchers used two transgenic mouse lines made from two different founders to 
substantiate that findings were not due to a genetic aberration from the transgenic 
method.  The enhanced lifespan in male mice was present in both transgenic lines.  The 
mean lifespan of SIRT6-transgenic relative to WT mice was increased by 14.8% and 
16.9% in the two SIRT6 transgenic lines compared to WT.  The reason for the longer 
lifespan in SIRT6 enhanced mice was not easily explained although the authors reported 
intriguing data and potential mechanisms (Kanfi et al., 2012).  Research has indicated 
that SIRT6 plays a crucial role in maintaining genetic stability (Mostoslavsky et al., 
2006) and because malignant tumors are a common cause of death in mice it is important 
to investigate tumor numbers in mice overexpressing SIRT6.  Examinations by Kanfi et 
al., (2012) showed no significant differences between WT and transgenic mice in the 
tumor spectrum or incidence. 
The study by Kanfi et al. also found differences in metabolic signaling including 
that SIRT6 overexpression had a positive effect on blood glucose regulation but this 
effect was not sex-specific (Kanfi et al., 2012).  Further analysis revealed significant 
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differences in metabolic signaling molecules and pathways between WT and SIRT6 
transgenic mice.  IGF1 levels were significantly different between male WT and 
transgenic mice but not between female mice and these differences coincided with 
differences in expression levels of IGFBP1 (Kanfi et al., 2012), the molecule believed to 
be the main acute effector of IGF1 levels (Lee et al., 1997).  Kanfi et al. also examined 
IGF1 signaling in some tissues and found that the levels of phosphorylated AKT, 
FOXO1, FOXO3, and IGF receptor were significantly lower in the white adipose tissue 
of male but not female SIRT6 transgenic mice.  These differences in IGF1-related 
molecules are especially intriguing given the relevance of IGF1 in the aging process 
(Kenyon, 2010; Holzenberger et al., 2003).  Although these findings do not explain the 
precise role of SIRT6 in aging it does suggest specific aspects that need to be further 
examined.       
 The current epidemic of obesity and metabolic syndrome compels investigations 
into whether anti-aging factors such as SIRT6 may be protective even in the context of 
obesity.  To explore these interrelationships, a recent study examined the effects of 
SIRT6 overexpression in mice in the context of diet-induced obesity (Kanfi et al., 2012).  
WT and SIRT6 transgenic mice were fed a high-fat diet (HFD) for 16 weeks that 
contained 60% of calories from fat.  In addition, separate groups of WT and SIRT6 
transgenic mice that consumed standard chow served as controls.  No significant 
differences between any of the four groups were found for food intake or body weight.  
However, when fed with HFD the SIRT6 transgenic mice had significantly lower total 
body fat and higher lean body mass than their WT littermates (Kanfi et al., 2012).  When 
fed HFD, SIRT6 transgenic mice also had lower serum triglycerides (33% lower), lower 
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LDL-cholesterol (30% lower) and improved glucose uptake during glucose tolerance 
testing.  Transcription profile analysis indicated that the SIRT6 transgenic mice had 
lower levels of angiopoietin-like protein 4 (ANGPTL4) and Diglyceride Acyl Transferase 
1 (DGAT1) as compared to their WT littermates (Kanfi et al., 2012).  ANGPTL4 
negatively regulates lipoprotein lipase (Yoshida et al., 2002), the enzyme that hydrolyzes 
triglycerides from plasma lipoproteins so a decrease in ANGPTL4 activity caused by 
elevated SIRT6 could be a mechanism that causes a decrease in plasma triglycerides.  
DGAT1 is an intracellular enzyme that is involved in triglyceride synthesis (Cases et al., 
1998) and the 50% decrease in DGAT1 expression in fat tissue of SIRT6 transgenic mice 
would be expected to significantly decrease triglyceride synthesis (Kanfi et al., 2012).  
Researchers were also able to determine that SIRT6 directly binds to the DGAT1 
promoter and that there was a 3.5-fold higher level of SIRT6 bound in the transgenic 
mice as compared to their WT littermates (Kanfi et al., 2012).  These data suggest SIRT6 
is an important repressor of DGAT1 expression.  Overall, results from the work of Kanfi 
et al., (2012) demonstrate SIRT6 overexpression is protective against HFD-induced 
damage such as lipotoxicity, increased body fat storage and aberrations in regulation of 
glucose homeostasis.       
 
SIRT6 and NF-ĸB  
 
 The family of transcription factors known as NF-ĸB has also been implicated in 
the aging process (Salminen et al., 2008).  One of the key components of NF-ĸB is the 
factor known as RELA or p65 because it has been shown to affect the regulation of a 
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variety of genes (Li et al., 2008).  A recent study provided evidence of a direct 
relationship between NF-ĸB and SIRT6 when it was shown that RELA interacts 
physically with SIRT6 thereby suggesting that these factors cooperate in regulating 
certain processes (Kawahara et al., 2009).  Researchers used immunoprecipitates (IPs) 
from 293T cells expressing FLAG-tagged SIRT6 and Western blot analyses to show 
SIRT6 binds RELA and it appears specific to SIRT6 as compared to other SIRT 
members.  When IPs were done using endogenous proteins it was also shown that RELA 
binds to SIRT6 preferentially over other SIRTs (Kawahara et al., 2009).  Chromatin 
immunoprecipitation (ChIP) analysis indicated TNF-α enhanced levels of SIRT6 bound 
to promoters of RELA target genes and that this resulted from RELA recruiting SIRT6 to 
the promoters of genes affected by RELA (Kawahara et al., 2009).  Subsequent 
experiments provided evidence that SIRT6 directly inhibits expression of certain NF-ĸB 
target genes and that the mechanism appears to be via SIRT6-directed deacetylation of 
histone H3 lysine 9 residues that destabilizes RELA binding to chromatin (Kawahara et 
al., 2009).  To substantiate these findings, it was also shown that SIRT6 depletion led to 
increased expression of NF-ĸB target genes and RELA deficiency via heterozygosity 
improved the phenotype of SIRT6 deficient mice (Kawahara et al., 2009).  Taken 
together, these findings point out a direct interaction of SIRT6 and NF-ĸB that has 
significant health implications.  Although the precise role of this interaction remains to be 
fully defined (Natoli, 2009), its potential importance to health and well-being makes it 
worthy of future research efforts.  
 Recent work has also focused on the relationship of SIRT6 and NF-ĸB and their 
genome-wide effects on gene expression.  A recent study utilized genome-scale ChIP-
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chip assays with oligonucleotide arrays to characterize the binding of SIRT6 and RELA 
in mouse embryonic fibroblasts (Kawahara et al., 2011).  The assays were done before 
and after stimulation with TNF-α to examine effects of the stress response of these two 
protein factors.  Results indicated that altogether SIRT6 can bind up to approximately 
5050 gene promoters including 1899 genes in unstimulated cells.  Upon TNF-α 
stimulation there was a significant and dynamic movement of SIRT6 from some 
promoters to others within minutes following TNF-α addition (Kawahara et al., 2011).  
Analyses also showed that RELA bound to 2738 promoters.  Assays revealed that on 
1481 promoters both SIRT6 and RELA bound and that RELA plays a significant role in 
SIRT6 localizing to certain gene promoters (Kawahara et al., 2011).  These findings 
provided more evidence of the cooperation of these two factors in regulating numerous 
genes in controlling cellular responses. 
 
NF-ĸB 
 
One of the popular theories of the aging process is known as the inflamm-aging 
theory of aging (Troen, 2003).  According to this theory, it is the systemic inflammation 
that results from enhanced oxidative stress during aging that causes the response of 
signaling pathways and effector molecules that promote tissue breakdown.  One of the 
key sensing and signaling molecules involved in this process is known as NF-ĸB 
(Salminen et al., 2008).  This molecule functions as a transcription factor that regulates 
the expression of numerous genes including those that can cause the breakdown of 
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skeletal muscle during aging, obesity, and/or insulin resistance.  Because of its crucial 
role in aging, the characteristics of NF-ĸB will be discussed in greater detail below. 
NF-ĸB is a transcription factor that has been determined to be a key signaling 
molecule in vertebrates because it reacts to a large number of stimuli, including oxidative 
stress, and is able to elicit a multitude of cellular responses including cellular life or death 
(Figure 11).  Previous work has suggested that NF-ĸB is involved in activating 
proteolysis leading to skeletal muscle loss in cachexia, sarcopenia, disuse atrophy, and 
aging. 
NF-ĸB is a well-characterized transcription factor that is expressed ubiquitously 
and is required for several critical processes including inflammation, infection, and 
oxidative stress (Salminen et al., 2008).  NF-ĸB is composed of a number of proteins 
(RelA/p65, cRel, RelB, p50, and p52), known as NF-ĸB family members that cooperate 
to form a complex. However, in most tissues p65/p50 heterodimers are most common  
and considered to be the “classic” active form of NF-ĸB.  NF-ĸB can be maintained in an 
inactive state in the cytosol through the binding of an inhibitor of ĸB (IĸB).  There are 
three isoforms of IĸB (IĸB, IĸB, IĸB) with each form possessing the ability to inhibit 
NF-ĸB.  Upon certain stimuli, IĸB is phosphorylated by IĸB Kinase (IKK) in a step that 
targets IĸB for ubiquitination and subsequent proteolysis thereby leaving NF-ĸB unbound 
(Li et al., 2008).  This process allows the unbound NF-ĸB to translocate to the nucleus 
where it can affect gene expression through binding NF-ĸB-target sequences located in 
the promoter region of specific genes (Figure 12). One of the hallmark features of NF-ĸB  
activation is an increased rate of proteolysis via the intracellular ubiquitin-proteasome 
pathway. NF-ĸB enhances the activity of several ligases involved in the ubiquitination 
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step and proteasome activity to increase protein breakdown (Cai et al., 2004).  Recently, 
studies have focused on how NF-ĸB may trigger skeletal muscle breakdown during 
disease states such as cachexia and disuse.  In addition, several recent studies have 
attempted to determine whether or not NF-ĸB may be a key regulator of skeletal muscle 
loss during aging however the mechanism remains unclear. 
 
 
 
Figure 11:  NF-ĸB signaling pathways.  The diagram represents a simplified version of 
the two NF-ĸB signaling pathways known as the “classical” and “alternative” pathways.  
(From Li et al., 2008) 
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Proteolysis Pathways 
 
Muscle loss occurs in adults for a variety of reasons such as disease, disuse and 
sarcopenia. Significant loss of skeletal muscle can have devastating effects including but 
not limited to reduced metabolic rate, reduced insulin sensitivity, reduced strength, 
increased prevalence of falls and inability to live and function independently.  Old age 
can result in a 20-30% decline in muscle mass over time and yet many of the cellular 
mechanisms responsible remain undetermined.   
Several cellular proteolytic systems exist but the four most prominent include the 
lysosomal system, the calcium-dependent system, the caspase-dependent processes and 
the ubiquitin-proteasome system.   Each system has different components and functions 
differently in the degradation of proteins.  The caspases belong to the family of cysteine 
proteases and have a prominent role in the apoptosis process under certain conditions.  
Although apoptosis and the caspases are crucial during certain events or conditions it is 
not yet clear how relevant caspases are in the regulation of muscle mass (Du et al., 2004; 
Moresi et al., 2008).  The calcium-dependent system also is composed of several cysteine 
proteases known as Calpains and at least one inhibitor called calpastatin.  Calpains tend 
to only hydrolyze a minimal amount of peptide bonds on their targets as they inactivate 
the protein or facilitate its degradation by other proteolytic pathways (Costelli et al., 
2005; Smith and Dodd, 2007).   
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Figure 12:  Activation of NF-ĸB p65/p50 heterodimer and translocation to NF-ĸB 
response elements in nucleus. 
 
 
The lysosomal system seems to be somewhat nonselective and appears to target 
the longer-lived proteins in cells (Kadowaki and Kanazawa, 2003).  The system has been 
shown to elicit elevated activity following a 6-hr nutrient starvation period so lysosomal 
autophagic activity seems to be sensitive to nutrient status (Grumati et al., 2010).  A class 
of cysteine proteases known as autophagins have been suggested to be involved in the 
 40 
formation of the autophagosomes and these proteins seem to be particularly abundant in 
skeletal muscle (Marino et al., 2003).  In addition, denervation or fasting has been shown 
to increase expression of autophagy-related genes during muscle atrophy (Mammucari et 
al., 2007; Ogata et al., 2010; O’Leary and Hood, 2009).  To summarize, the lysosomal 
system appears to have a significant role in muscle proteolysis. 
Most evidence indicates that the Ubiquitin-proteosome system (UPS) is the 
dominant system of proteolysis in muscle cells (Attaix and Taillandier, 1998).  Activity 
of the UPS can be upregulated under numerous conditions including disease (e.g. cancer 
cachexia), disuse, or stress such as nutrient deprivation.  Aging also appears to enhance 
the activity of the ubiquitin-proteosome pathway and it has been reported that the 
decrease in proteosome activity that occurs following a meal in young adult rats is not as 
significant in older rats.  In other words, proteolysis occurs at a higher level in older rats 
than in adult rats following a meal.  However, an elevated level of leucine restored the 
postprandial inhibition of proteolysis in old rats (Combaret et al., 2005).  These data 
suggest the ubq-proteasome pathway is leucine-sensitive and that older animals may 
require elevated levels of leucine to down-regulate proteolysis.  Proteasomes are large 
multi-subunit complexes found in the nucleus and cytosol that selectively degrade 
intracellular proteins that have had ubiquitin attached. Ubiquitin is a highly conserved 76-
amino acid protein that signals proteins to be transported to the multi-enzyme proteolytic 
complex known as the 26S proteasome. The proteosome core is composed of 28 subunits 
arranged in four heptameric, tightly stacked, rings to form a cylindrical structure. In the 
ubiquitin-proteosome degradation pathway, Ubq is first covalently ligated to target 
proteins by a multi-enzymatic system consisting of Ubiquitin-activating (E1), Ubiquitin-
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conjugating (E2), and the Ubiquitin-ligating (E3) enzymes.  Poly-ubiquitination of the 
substrate protein results in the protein being targeted to the proteosome for degradation.  
Two novel E3 ubiquitin ligases have been identified and described to be specifically 
expressed only in cardiac and skeletal muscle (Bodine et al., 2001).  The ligases were 
referred to as atrogin-1 (muscle atrophy F-box) and MuRF-1 (muscle ring finger 1).  
Studies have shown these ubiquitin ligases to be upregulated by TNFα, NF-B (Cai et al., 
2004) and reactive oxygen species (Li et al., 2003).  A study by Clavel et al., (2006) 
indicated that atrogin-1 and MuRF1 were upregulated in age-related proteosome-
dependent proteolysis in rat tibialis anterior muscle. Moreover, in studies using chickens, 
leucine was found to decrease myofibrillar proteolysis by down-regulating the ubiquitin-
proteosome pathway (Nakashima et al., 2005). Leucine deprivation was shown to 
increase components of the ubiquitin-proteosome pathway in mouse C2C12 cells (Sadiq 
et al., 2007).  Specific details regarding key leucine-dependent signaling molecules 
remain to be determined. 
 
Leucine Effects 
 
Typically in adults the amount of muscle tissue present depends upon the balance 
between muscle protein synthesis (anabolism) and breakdown (degradation or 
proteolysis).  Numerous conditions, hormones, and nutrients play key roles in the balance 
between anabolism and muscle proteolysis.  For example, it has been known for years 
that leucine, an essential amino acid for humans, is an extremely important signaling 
molecule in muscle cells.  Leucine appears to have a unique role in cellular signaling 
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pathways that regulate protein synthesis and protein breakdown. The anti-catabolic 
effects of leucine were reported over 45 years ago (Hider et al., 1960) and extensive work 
since then has confirmed the anti-catabolic effect and some of the mechanisms have been 
defined.  Experiments indicated the leucine metabolite β-hydroxy-β-methylbutyrate 
(HMB) is responsible for leucine’s ability to decrease protein breakdown (Nissen et al., 
1996).  Follow up studies have shown leucine and HMB decrease protein degradation by 
decreasing activity of the ubiquitin-proteasome proteolytic pathway (Combaret et al., 
2005; Nakashima et al., 2005; Smith et al., 2005).  Evidence indicates sufficient amounts 
of leucine promote protein synthesis through both insulin-dependent and insulin-
independent signaling pathways (Kadowaki and Kanazawa, 2003; Kimball and Jefferson, 
2006).  Leucine is able to activate cellular signals that initiate protein translation via 
mammalian target of rapamycin (mTOR) signaling and activation of the protein 
elongation initiation factor known as eIF4G (Layman and Walker, 2006; Kimball and 
Jefferson, 2001; Crozier et al., 2005).  Leucine’s activation of these proteins leads to 
increased activity of the ribosomal translation complex and elevated protein synthesis 
levels in cells.   
Lack of leucine (or certain other amino acids) within a cell can initiate a pathway 
known as the amino acid response pathway.  This results in activation of the protein 
GCN-2 (general control nonderepressible) a kinase that phosphorylates the translation 
elongation factor eIF-2α that causes a nearly comprehensive decrease in protein synthesis 
(Kilberg et al., 2009).  However, a mammalian protein known as ATF-4 (activating 
transcription-4) is actually translated at a higher level during those conditions (Kilberg et 
al., 2009).  ATF-4 has been reported to increase the expression of CHOP (C/EBP 
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Homology Protein) also known as gadd153 (growth arrest and DNA damage protein 
153).  One function of CHOP has been defined as activation of the ER (endoplasmic 
reticulum) stress response which, among other things, may induce oxidative stress within 
a cell (Kilberg et al., 2009).  Cells may respond to oxidative stress by activating stress 
response molecules such as the transcription factor NF-ĸB.  Details of the NF-ĸB 
pathway were provided in a previous section. 
Because leucine can decrease protein breakdown and increase protein synthesis, 
the net increase in cellular protein levels can be significant.  Therefore, adequacy of 
leucine intake is important to help ensure protein synthesis and retention can be positive 
at the appropriate times and conditions throughout a person’s life.  Recent studies have 
suggested that higher levels of leucine may be required in elderly individuals to decrease 
skeletal muscle breakdown as compared to young individuals (Katsanos et al., 2006) 
because of leucine’s ability to trigger anabolic and anti-proteolytic signaling pathways 
(Nakashima et al., 2005).  Studies have emerged to suggest that a level of protein intake 
higher than the current recommendations may facilitate muscle retention in the elderly, 
possibly due to leucine’s protective effect on skeletal muscle retention.  Given the high 
prevalence of sarcopenia and importance of leucine in protein metabolism, the amount of 
protein and leucine intake should consistently and systematically be considered and 
evaluated as a means to minimize the detrimental effects of sarcopenia. 
 
 
 
SUMMARY 
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In summary, there is a great deal more that needs to be investigated and 
understood about the aging process.  This is especially relevant given increasing lifespan 
and numbers of persons that are or will soon reach the elderly category.  In order to 
improve the health and well-being of the elderly it is important to understand the aging 
process so that effectiveness of the dietary and lifestyle intervention strategies can be 
evaluated based on specific and well-described processes involved in aging.  For 
example, the fairly recent discovery of the Sirtuin family members has provided 
important insight into the aging process and appears to be a promising avenue for the 
future studies.  These efforts should include how diet and lifestyle may influence the 
Sirtuins as a means of extending lifespan and improving quality of health.  Another 
example is the highly-studied transcription factor known as NF-ĸB because it has been 
shown to play a key role in so many processes including those involved in aging.  
Although much is known about NF-ĸB there are still important aspects that need to be 
explained especially given recent information that ties NF-ĸB and specific Sirtuins 
together in the aging phenotype.  The research described below was performed to provide 
information related to SIRT6 and NF-ĸB by measuring protein levels of each in various 
tissues of adult and old rats.  We hypothesize that NF-ĸB (p65) protein levels would be 
elevated in tissues of the old rats relative to adult rats.  We also hypothesize that SIRT6 
protein levels would be lower in the tissues of the old rats as compared to the adult rats.  
Hopefully, this information contributes toward a better understanding of how these 
proteins are involved in the aging phenotype. 
MATERIALS AND METHODS 
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In view of the gaps in knowledge related to molecular mechanisms of aging, we pursued 
an experimental strategy to provide insight into how NF-ĸB and SIRT6 protein levels 
differ in adult and old rats.  Our goal was to gather information from this study that may 
be used to guide future experiments and/or nutritional and lifestyle interventions that may 
affect NF-ĸB and SIRT6 in a beneficial manner.  We hypothesized that NF-ĸB levels 
would be higher in tissues of the old rats and that this may be associated with loss of 
tissue mass.  We hypothesized that SIRT6 levels would be lower in some tissues of the 
old rats and that lower levels of SIRT6 may be associated with higher levels of NF-ĸB.  
To examine these questions, two groups of rats of adult and old age were fed the same 
diet for the same amount of time prior to their sacrifice and tissue excision.  Western blot 
analyses were performed to quantify and compare levels of NF-ĸB and SIRT6 protein 
between tissues and age groups.  Details of experimental procedures are described below. 
 
Animals 
A total of 14 male Sprague Dawley rats were purchased from Harlan 
(Indianapolis, IN) at ages 6 months and 21 months (n=7/age-group). All animal 
procedures were approved by the Cal Poly Institutional Animal Care and Use Committee.  
Based on the typical lifespan of Sprague Dawley rats, the 6-month-old rats were 
designated Adult and the 21-month-old were designated Old.  Rats were housed in 
individual cages on a 12-hour light cycle in a temperature-controlled room. Upon arrival, 
rats were provided basic chow diet for three days prior to changing to the experimental 
diet, (product # 510018 modified Leucine level, Dyets, Inc., Bethlehem, PA) for ad 
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libitum consumption for 10-17 days.  Experimental diet was a low-leucine formula that 
contained all other essential nutrients as shown in Table 1.  Rats were fasted for 
approximately 12 hours then killed by CO2 inhalation.  Rat weights and food intake were 
measured daily. 
 
Tissue Preparation 
Excised tissue was cut up in T-PER (~0.2 g per 4 mL T-PER) was placed into 
chilled T-PER (Thermo Scientific, Rockford, IL) with protease inhibitor and EDTA (4 
mL T-PER + 40 uL HALT protease inhibitor + 40 uL 0.5 M EDTA) (Thermo Scientific).  
Tissue was homogenized with a chilled polytron while being kept on ice at all times.  
Homogenate was centrifuged at 10,000 g for 5 minutes at 4ºC and supernatant stored at 
−80ºC in aliquots to avoid freeze-thaw cycles. 
 
SDS PAGE and Transfer to Nitrocellulose Membrane 
Tissue protein was quantitated using a standard calibration curve (BCA Protein 
Assay Kit, Thermo Scientific) by combining 5 uL sample and 45 uL T-PER.  SDS PAGE 
was performed using BIO-RAD Mini-Protean II System (Bio-Rad, Richmond, CA) with 
4-20% Precise acrylamide pre-made gels (Thermo Scientific) run with a HEPES 
buffering system.  Fifty ug of protein was loaded per each well and then SDS-PAGE and 
Western blotting was performed.   A sample from Jurkat cell nuclear extract (Santa Cruz 
Biotechnology, Santa Cruz, CA) was also loaded on each gel and used as a positive 
control to locate and quantify the NF-ĸB p65 and SIRT6 bands.  Each well was loaded  
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with 50 ug tissue protein (tissue supernatant, load buffer at 20% v/v, and T-PER to a total 
volume of 37.5 uL), 10 uL Rainbow molecular weight markers, and 15 uL Jurkat cell 
nuclear extract as a positive control for p65 (5 uL Jurkat, 10 uL load buffer, 35 uL T-
PER).  All samples were boiled for four minutes prior to loading.  Gels were run at 100 V 
for 5 minutes followed by 80 V for 70 minutes.  After electrophoresis, gels and 
nitrocellulose membranes were soaked in methanol-containing transfer buffer (BupH 
Tris-Glycine Buffer; Pierce, Thermo Scientific) for 15 minutes.  Filter paper was soaked 
in transfer buffer for approximately 30 seconds, until fully absorbed.  A semi-dry gel, 
membrane, filter paper sandwich was created carefully to assure uniform contact between 
layers.  The Semi-dry Trans-blot system (Bio-Rad) was run at 15 V for 45 minutes.  
Membranes were then dried overnight at room temperature. 
 
Western Blotting 
Membranes were washed on a rocking platform three times (20 mL) for 5 minutes 
in 1x TBS with 0.5% Tween-20.  Blocking (TBS Starting Block with 0.5% Tween-20; 
Thermo Scientific) was performed for 20 minutes (20 mL), followed by two additional 
washes.  Anti-p65 NF-ĸB antibodies (Santa Cruz Biotechnology) or anti-SIRT6 
antibodies (Sigma, St. Louis, MO) were applied for 90 minutes diluted in 15 mL 
Blocking solution (Thermo Scientific).  Dilutions were 1:400 for anti-p65 NF-ĸB and 
1:750 for anti-SIRT6.  Membranes were washed five times and then secondary antibodies 
(ImmunoPure Goat Anti-Rabbit IgG (H+L) Peroxidase Conjugated (Thermo Scientific)) 
were applied for 60 minutes.  Membranes were washed an additional five times.  
Membranes were then exposed to ECL reagents (SuperSignal West Dura Extended 
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Duration Substrate) for 5 minutes (Pierce, Thermo Scientific) prior to visualization and 
quantitation of bands on a Chemi Doc System (Bio-Rad) using Quantity One software 
(Bio-Rad).  Various amounts of rat tissue and jurkat protein were analyzed by Western 
blots for p65-NF-ĸB and SIRT6 to first establish linearity and specificity of the 
procedures.  Subsequently, appropriate amounts of protein were used for Western blot 
analyses.  The Jurkat cell nuclear extract was used to quantify relative amounts of p65 
and SIRT6 in samples by expressing band density values after ECL per the Jurkat value 
on each membrane.  A flowchart of the experimental design has been provided below as 
Figure 13. 
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Adult Rats (age 6 months) 
 
Old Rats (age 21 months) 
 
 
 
Rats were fed a commercially-prepared diet ad libitum for 10-17 days. 
Rats were housed individually and dietary intake was measured daily. 
Tissue total cellular protein was prepared by polytron homogenization on ice 
in chilled T-PER (Thermo Scientific) containing 
HALT protease inhibitors (Pierce) and EDTA. 
Supernatant was obtained by centrifugation and 
protein was quantitated by BCA Assay prior to electrophoresis. 
Rats were killed by CO
2
 inhalation and tissues were excised and 
immediately frozen in liquid nitrogen and placed at -80C. 
 51 
Figure 13:  Flowchart of experimental design. 
RESULTS 
 
Body and Tissue Weights 
Rats in the Old age group had a significantly higher body weight than the Adult 
rats (Table 2).  Table 2 shows the average daily intake per group over the entire time 
period from the time the low-leucine diet started to the time of sacrifice.  Although there 
was a significant difference in body weight, there was not a significant difference in daily 
food intake between the two groups when the data were expressed as grams of food per 
day (Table 2).  However, when food intake data were expressed relative to body weight 
the differences were significant and indicated the Old rats consumed less food per day per 
body weight (Table 2). 
 
 
 
Numerous tissues were removed and weighed after the rats were killed to examine 
the effects of age on tissue size.  The weights of the tissues are shown in Table 3.  Pieces 
of liver and quadriceps were used for tissue analyses but because these were not excised 
in their entirety the weights were not recorded.  There was a significant difference in 
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gross average tissue weights in tibialis anterior, heart, kidney, and lungs (Table 3).  
However, tissue and muscle weights were also expressed relative to overall body weight 
(Table 4).  Weights of excised Soleus and Gastrocnemius muscles were significantly 
different in Old vs. Adult rats when values were expressed per body weight (Table 4).   
 
 
 
 53 
 
Levels of NF-ĸB (p65) in Various Tissues 
In order to examine the tissue levels and the effect of aging on NF-ĸB (p65) 
levels, samples of total protein were prepared from each of the isolated tissues.  SDS-
PAGE and Western blot analysis was then used to quantitate levels of NF-ĸB (p65) in the 
Adult and Old rats.  Differences of NF-ĸB (p65) were first compared between tissues in 
the Adult rats Figure 14A.  Results indicated NF-ĸB (p65) was significantly higher in 
lung as compared to gastrocnemius, heart, kidney, quadriceps and tibialis anterior (Figure 
14A).  NF-ĸB (p65) was significantly higher in the liver than kidney, quadriceps and 
tibialis anterior in the Adult rats (Figure 14A).  In addition, heart levels of NF-ĸB (p65) 
were significantly higher than tibialis anterior (Figure 14A).  The amount of NF-ĸB (p65) 
protein in the soleus muscle was significantly higher than the tibialis anterior muscle 
(Figure 14A).   A maximum number of 7 samples were analyzed but some analyses were 
performed using 4 samples because of unlikely differences. 
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Tissue levels of NF-ĸB (p65) were also compared in the Old rats (Figure 14B).  
The amount of NF-ĸB (p65) protein in the lung was significantly higher than 
gastrocnemius, heart, kidney, liver, quadriceps, soleus and tibialis anterior (Figure 14B).  
Levels of NF-ĸB (p65) in the liver were significantly higher than gastrocnemius, 
quadriceps and tibialis anterior (Figure 14B).  NF-ĸB (p65) protein in the kidney was 
significantly higher than that of the tibialis anterior (Figure 14B).  Soleus levels of NF-ĸB 
(p65) were significantly elevated as compared to tibialis anterior (Figure 14B).  The 
comparison of NF-ĸB (p65) protein levels between tissues indicated some interesting 
findings including that levels in the lung were significantly higher than other tissues in 
both the Adult and Old rats (Figure 14A and 14B). 
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 Additional analyses were done to compare NF-ĸB (p65) protein levels of Adult 
and Old rats in specific tissues (Figures 15 and 16).  Comparisons between age groups 
revealed that gastrocnemius NF-ĸB (p65) was significantly higher in the Old rats as 
compared to the Adult rats (Figure 15A).  Quadriceps NF-ĸB (p65) tended to be higher in 
the Old rats as compared to the Adult rats (Figure 15B) but the differences did not reach 
statistical significance (P = 0.063).  Levels of NF-ĸB (p65) in the kidney appeared to be  
approximately 40% higher in the Old compared to Adult rats but the values were not 
statistically significant.  These data indicate NF-ĸB (p65) protein levels are regulated in a 
tissue-specific and age-dependent manner in rats. 
 
Levels of SIRT6 Protein in Various Tissues 
Duplicate SDS-PAGE gels and transfers were run simultaneously so that NF-ĸB 
(p65) could be examined on one nitrocellulose membrane and SIRT6 on the duplicate 
membrane.  SIRT6 protein levels in various tissues were compared in both the Adult and 
Old rats (Figure 17).      
In both the Adult and Old rats, the following statistically significant differences in 
SIRT6 were observed (Figure 17A and 17B).  SIRT6 was significantly higher in 
quadriceps and kidney as compared to soleus.  SIRT6 protein in the quadriceps, 
gastrocnemius, tibialis anterior and kidney was significantly higher than SIRT6 in the 
liver.  SIRT6 was significantly lower in lung and heart as compared to quadriceps.  
Gastrocnemius, tibialis anterior and kidney SIRT6 protein levels were significantly 
higher than those of lung tissue.  There was also a significant difference between SIRT6 
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levels of the heart versus the gastrocnemius muscle.  In addition, tibialis anterior and 
kidney levels were significantly higher than heart SIRT6.   
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Analyses were also performed to compare the effect of age on SIRT6 protein 
levels in specific tissues (Figures 18 and 19).  The comparisons between age groups 
indicated SIRT6 was not significantly different between the Old and Adult rats in any of 
the tissues examined (Figures 18 and 19).  These data suggest that SIRT6 in rats is 
regulated in a tissue-specific manner.  However, we did not detect age-dependent 
differences  between tissues for SIRT6 protein levels.  
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DISCUSSION 
 
 This study compared effects of aging in Adult (6-month old) and Old (21-month 
old) Sprague Dawley rats.  The average life span of Sprague Dawley rats has been 
reported to be approximately 25 months (Cameron et al., 1982) so 21-months represents a 
stage near the end of their lifespan.  We hypothesized that older rats would display 
increased markers of muscle cell stress and inflammation (specifically, NF-ĸB).  To 
minimize potential effects of diet on these parameters, upon arrival rats consumed the 
same control diet for approximately three days before being fed the same experimental 
diet ad libitum for 10-17 days.  Because of the difference in age, the Old rats had body 
weights that were significantly higher than the Adult rats.  Although body fat was not 
measured, Old rats also had visibly higher amounts of body fat that was apparent during 
excision of tissues. The Old rats were also noticeably less active than their younger 
counterparts.  It should be noted that the experimental diet provided had lower than 
recommended amounts of leucine as a means of potentially increasing proteolysis of 
aging.  However, both groups consumed the same amount of diet per day in terms of 
grams. 
 A number of tissues including four different muscles were excised to measure 
their mass and their NF-ĸB (p65) and SIRT6 protein levels.   NF-ĸB is a transcription 
factor complex that regulates a variety of genes in numerous processes including muscle 
proteolysis during aging.  NF-ĸB complexes can function either as transcriptional 
activators or repressors depending on their specific components (Hayden and Ghosh, 
2004).  NF-ĸB containing p65/p50 and p65/p52 heterodimers have been found to 
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function as transcriptional activators (Hayden and Ghosh, 2004) while p52/p52 and 
p50/p50 heterodimers function as transcriptional repressors (Li and Verma, 2002).  
Studies have indicated that p65 is a key component for up-regulating NF-ĸB-dependent 
transcription (Schmitz and Baeuerle, 1991) and that muscle p65 nuclear protein levels are 
increased during hindlimb immobilization in rats (Bar-Shai et al., 2005).  p65 effects are 
also regulated by SIRT6 as the two proteins interact (Kawahara et al., 2009).  We 
hypothesized levels of NF-ĸB (p65) and SIRT6 would be affected by age in specific 
tissues.  To the best of our knowledge, we believe this is the first study to compare levels 
of these proteins in various tissues of Adult and Old rats. 
 The pattern of protein levels in tissues appeared to be quite different for NF-ĸB 
(p65) and SIRT6.  We observed differences in NF-ĸB (p65) protein levels between 
tissues with the highest level being in lung although in the Adult rats differences between 
lung, liver, and soleus did not reach statistical significance.  Tissue levels of SIRT6 had a 
quite different pattern from that of NF-ĸB (p65).  There was not any single tissue that 
expressed significantly higher levels of SIRT6 relative to the other tissues.  Instead, there 
appeared to be a pattern of four tissues with higher levels of SIRT6 in both age groups.  
The pattern of NF-ĸB (p65) vs. SIRT6 protein levels is different and most likely 
unrelated although additional studies would be needed to confirm this is the case in these 
tissues. 
 Our experiments included comparisons of NF-ĸB (p65) and SIRT6 between age 
groups in each specific tissue.  In most tissues, it appeared that aging did not alter NF-ĸB 
(p65) or SIRT6 protein levels.  However, NF-ĸB (p65) levels in the kidney and 
quadriceps were more than 25% higher in the Old rats vs. Adult rats although differences 
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did not reach statistical significance.  Interestingly, the higher level of NF-ĸB (p65) in 
gastrocnemius of Old rats was significant.  The observation that the weight of 
gastrocnemius muscle in Old rats was significantly less than that of Adult rats raises the 
possibility that the elevation in NF-ĸB (p65) in gastrocnemius in Old rats was involved in 
enhanced proteolysis and loss of gastrocnemius tissue.   
 Tissue atrophy is commonly associated with the aging process.  However, tissue 
atrophy can be categorized as either cachexia or sarcopenia.  Cachexia is typically related 
to cancer and other inflammatory diseases and it can affect numerous tissues including 
skeletal muscle (Delano and Moldawer, 2006; Morley et al., 2006).  Sarcopenia is 
specifically related to muscle wasting during aging (Greenlund and Nair, 2003; Thomas, 
2007).  Muscle atrophy through protein turnover can occur due to reduced protein 
synthesis, enhanced proteolysis or both (Jackman and Kandarian, 2004; Ventadour and 
Attaix, 2006; Eley and Tisdale, 2007).  There is a diverse array of physiological stimuli 
that regulate protein turnover during various conditions and stages of the life cycle.  In 
general, insulin and its signaling pathway stimulate protein synthesis and decrease 
proteolysis in one of the most significant regulators of muscle addition and retention.  
Therefore, a loss of insulin production or signaling effectiveness can have devastating 
effects in disease states such as diabetes or the process of aging.   
Other hormones and cytokines including TNF-α also play a significant role in 
muscle loss during certain diseases, obesity and aging.  Although extensive research has 
detailed a large number of molecules involved in tissue atrophy, the research has also 
shown that one of the key molecules in numerous signaling pathways and conditions is 
NF-ĸB.  For example, NF-ĸB activation can attenuate insulin signaling thereby 
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enhancing muscle loss.  Increases in the cytokine TNF-α also increase NF-ĸB activity, 
and vice versa, in a regulatory process that also affects muscle atrophy.  Unfortunately, 
we were not able to assess the status of insulin signaling or TNF-α levels in our rats in the 
current study but given the obesity and age of the Old rats it could very well be that both 
were affected and this could explain some of our findings. 
Many studies have shown NF-ĸB regulation to be via phosphorylation-dependent 
activation and translocation to the nucleus for enhanced DNA-binding to promoter 
regions of target genes.  However, we observed a significant increase in NF-ĸB (p65) 
protein levels in the whole cell lysate indicating that under certain conditions the actual 
protein level of NF-ĸB (p65) is regulated.  This suggests the increase in NF-ĸB (p65) 
protein level in the Old rats corresponded with an increase in activated NF-ĸB (p65) 
protein and its dependent pathways.  One such pathway is the ubiquitin proteolysis 
pathway, the major pathway for protein breakdown in muscle tissue.  Indeed, research 
has shown that NF-ĸB binds to the promoter of murine ring finger-1 (MuRF1), an E3 
ligase involved in ubiquitin conjugation and increases its expression (Cai et al., 2004).  
Our methods did not distinguish between cellular locations so we could not determine if 
the elevated NF-ĸB (p65) protein level in gastrocnemius of Old rats was due to an 
increase in cytosolic or nuclear NF-ĸB (p65) protein.  Whatever the case, there appeared 
to be more functional NF-ĸB (p65) protein given that increased proteolysis is a plausible 
reason for reduced gastrocnemius mass in the Old rats. 
 Our observation of elevated NF-ĸB (p65) protein in gastrocnemius makes this a 
relatively unique study.  Rather than measuring protein levels, numerous other studies 
have instead focused on the activation of NF-ĸB (p65) by measuring its DNA-binding 
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activity.  This has been done in various conditions including several models to study the 
effects of aging on NF-ĸB (p65) activation in muscle as well as other tissues.  For 
example, Zaidi et al., (2005) reported a ~10-fold increase in NF-ĸB DNA binding in the 
liver of 24-month old rats.  Although aging significantly increased DNA-binding activity 
there was not a concomitant increase in p65 protein levels (Zaidi et al., 2005).  Similar 
observations were reported in the hippocampus (Kaufmann et al., 2002), cerebellum and 
frontal cortex (Korhonen et al., 2002) and cardiac sarcoplasm (Helenius et al., 1996) of 
old rats.  These studies provide evidence that DNA-binding activity of NF-ĸB may 
increase even in the absence of an increase in cellular NF-ĸB (p65) protein levels.  
 Rather than measuring NF-ĸB (p65) activation, we chose to focus our efforts on 
measuring NF-ĸB (p65) protein levels in the context of tissue and age specific effects.  
There have been a few studies that reported NF-ĸB (p65) protein levels were elevated due 
to aging or other conditions.  For example, Helenius et al., (2001) reported that in rat 
liver, aging led to increased NF-ĸB DNA binding activity as well as increased nuclear 
and cytosolic p52 and p65 protein levels.  There were not age-associated changes in 
mRNA levels for p52 or p65, thereby suggesting gene expression was not altered by age 
(Helenius et al., 2001).  A different study compared the effects of aging in the heart, liver, 
kidney and brain of both mice and rats by measuring both DNA binding and protein 
levels of p50, p52, and p65 NF-ĸB components (Helenius et al., 1996).  Findings 
indicated aging was associated with a strong increase in NF-ĸB DNA binding activity in 
both rats and mice in all tissues studied (Helenius et al., 1996).  Protein levels of p50, 
p52, and p65 in the cytosolic fractions were not increased by age in the old rats and mice.  
However, p52 protein levels in the nuclear fraction of heart and liver nuclear fraction of 
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old animals significantly increased (Helenius et al., 1996).  These findings suggest aging 
can cause a differential increase in nuclear rather than cytoplasmic levels of NF-ĸB 
protein components and this is at least partially responsible for the increase in DNA 
binding activity of NF-ĸB that usually occurs during aging.  We did not separate nuclear 
and cytoplasmic fractions in our study but it seems likely that the increase in p65 protein 
in gastrocnemius was due to an increase in the nuclear fraction.    
The decision to investigate SIRT6 was based on its putative role in aging and its 
relationship with NF-ĸB.  Recently, elaborate studies by Mostoslavsky et al., (2006) 
showed that SIRT6-deficient mice are small and quickly develop significant 
abnormalities that include lordokyphosis, lymphopenia and significant metabolic 
disorders including altered glucose and IGF-1 homeostasis.  In addition, they showed that 
SIRT6-deficient mouse cells had increased sensitivity to DNA-damaging agents 
(Mostoslavsky et al., 2006).  Moreover, many of these characteristics in SIRT6-deficient 
mice are indicative of premature aging and indeed the life span of  SIRT6-deficient mice 
is significantly reduced suggesting SIRT6 is a regulator of aging (Jia et al., 2012).  A 
direct link between SIRT6 and aging was recently reported when Kawahara et al., (2009) 
described how SIRT6 downregulates NF-ĸB signaling by binding to p65 of  NF-ĸB.  This 
can result in deacetylation of histone H3K9 residues located in NF-ĸB target gene 
promoters and modulation of aging effects (Kawahara et al., 2009).  This likely 
represents an important mechanism of how SIRT6 promotes longevity.  Given the 
relevance of SIRT6 in NF-ĸB signaling and aging we believe our data on tissue and age-
specific effects on SIRT6 protein levels provides useful information toward 
characterization of SIRT6. 
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 Our data showed SIRT6 is regulated in a tissue-specific manner.  When we 
compared SIRT6 protein levels of Adult vs. Old rats in each of the tissues we did not 
observe statistically significant differences.  Because of the role of SIRT6 in aging, we 
expected to see a decline in at least some of the tissues of the Old rats.  However, it is 
possible that SIRT6 was affecting its downstream targets differently in Adult and Old rats 
in ways that did not require alterations in SIRT6 protein levels.  Research in SIRT6-
regulated effects is still in the early stages so it has not yet been determined if changes in 
SIRT6 protein levels are a major point of regulation.  Recent studies such as that by 
Kawahara et al., (2011) have provided information about transcriptional networks related 
to SIRT6 and as the research in SIRT6 moves forward it should become more clear as to 
whether or not SIRT6 protein levels are commonly altered for regulatory effects or if 
other mechanisms are involved in modulating SIRT6 targets. 
 In summary, it was found that the level of NF-ĸB (p65) protein was significantly 
higher in the gastrocnemius of Old as compared to Adult rats, and there were upward 
trends in some other tissues.  p65 and SIRT6 protein levels were also significantly 
different between many of the tissues.  Therefore, both NF-ĸB(p65) and SIRT6 were 
regulated in a tissue-specific manner while only NF-ĸB(65) was also regulated by age in 
specific tissues.  We believe our findings provide interesting information in the potential 
roles of NF-ĸB and SIRT6 in the aging process. 
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CONCLUSIONS 
 
 Recent research has examined some of the mechanisms that may be involved in 
sarcopenia and as a result some of the cellular molecules involved in sarcopenia and the 
aging process have been identified.  One set of molecules that seem to play a key role in 
aging are known in mammals as the Sirtuins.  These proteins were first identified as 
being related to longevity because of their role in caloric restriction and increased life 
span in several organisms other than humans.  Although the role of Sirtuins in humans 
remains relatively unclear, evidence has indicated the Sirtuins regulate the expression of 
a large number of genes by altering chromatin structure and the activity of the Sirtuins 
can be affected by diet and exercise.  Data from the current study indicated that SIRT6 
levels were significantly different between some of the tissues examined in rats.  
However, it did not appear that tissue differences in SIRT6 were affected by age. 
 Research has also determined that a protein complex known as NF-ĸB plays a 
significant role in regulating some of the processes involved in aging.  NF-ĸB is one of 
the most well-studied transcription factors because it plays a role in so many pathways in 
the body and it is unique because it both a sensor and signaling molecule.  Evidence has 
shown that NF-ĸB responds to dietary components and exercise regimens thereby making 
it a potential target for strategies to minimize negative effects of aging.  The data from 
our study indicated that p65 (NF-ĸB) levels were significantly different between several 
tissues.  Findings also showed that p65 (NF-ĸB) was significantly higher in the 
gastrocnemius of old rats as compared to the adult rats suggesting age played a role in the 
increase.  
 Although the current study provided interesting results there are several items that 
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should be considered when reviewing these findings and planning future studies that are 
similar in design and focus.  One of the obvious considerations is that larger sample size 
numbers may have been beneficial.  This may have altered results and allowed the 
detection of significant differences that were not evident with current sample 
numbers.  To address this, data from the current study could be used for statistical power 
analysis to estimate appropriate sample size for the next set of experiments.  Indeed, there 
appeared to be a few relatively large differences in mean values that may have reached 
significance if the sample size was larger.   
Another potential consideration for future work would be to alter the methods of 
protein analysis.  For Western blot analyses, blots could be stripped and probed for a 
control such as actin or tubulin.  These proteins are often used a controls because their 
levels are rarely changed by treatments and provide a method to verify that the same 
amounts of sample protein were loaded in each gel lane and was transferred to the 
membranes.  Additionally, more than one source of primary antibodies could also be used 
for Westerns to verify results were treatment or age specific rather than due to antibody 
binding.  Although this is rarely considered necessary it could be an additional means to 
validate findings. 
Future experiments could also take the next step by quantifying effects of p65 
(NF-ĸB) and SIRT6 targets.  For example, levels of MuRF-1 protein could be quantified 
because as a target of p65 (NF-ĸB) it would be expected that MuRF-1 would be elevated 
in tissues with higher p65 (NF-ĸB) levels.  This would be a way of indicating that the 
higher levels of p65 (NF-ĸB) in gastrocnemius of old rats was causing downstream 
effects.  Another option for future experiments would be to add methods that quantify 
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activity of SIRT6 such as measuring its ability to bind the chromatin at specific locations 
or its binding to p65 (NF-ĸB).  Although we measured both SIRT6 and p65 (NF-ĸB) 
protein levels we did not directly compare their levels.  Perhaps this could be viewed as a 
weakness of our study because other studies have shown a direct interaction between the 
two proteins and shown that SIRT6 attenuates some p65 (NF-ĸB) effects.  We could have 
possibly devised a way to compare levels of each using a statistical approach. 
Alternatively, it would have been possible to compare levels had we used actin or 
tubulin as a control and used it to compare levels of SIRT6 and p65 (NF-ĸB) relative to 
the control in each tissue.  This could be an intriguing addition to future 
studies.  Although hindsight appears to indicate some shortcomings in our study, we still 
believe our data provides some interesting and worthwhile information about SIRT6 and 
NF-ĸB. 
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